+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 12Years +
All Genders
Healthy Volunteers
ID07456969

Clinical Evaluation of a Breath-Based Non-Invasive Diagnostic Tool for Malaria Detection Using VOC Biomarkers in Ethiopia

Led by Foundation for Innovative New Diagnostics, Switzerland · Updated on 2026-09-04

200

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are developing a non-invasive tool to diagnose malaria by detecting volatile organic compounds VOCs in breath. This study focuses on confirming the link between specific VOCs and malaria infection using thermodynamic sensors. The goal is to offer a rapid, painless alternative to blood tests for malaria detection. The project builds on prior identification of six potential VOC biomarkers associated with malaria. The study involves collecting breath samples from individuals aged 12 and older who have a fever and are suspected of having malaria at two health clinics in Ethiopia. PCR tests on blood samples will confirm malaria infection status, serving as a reference. The TRACE-E device will be used to perform non-invasive breath tests to detect the candidate VOC biomarkers and potentially identify others. Participants will provide breath samples and undergo blood tests for PCR confirmation. Researchers will analyze these samples to evaluate the presence of malaria-related VOCs in breath. The primary outcome measurement is scheduled between June and September 2026. The study aims to gather high-quality clinical data to validate the diagnostic approach, with the total study completion expected by the end of 2026.

CONDITIONS

Brief Title

Non-invasive Malaria Diagnostic Data Collection in Ethiopia

Research Team

A

Andres De la Rossa, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here